Naproxen Sodium 220mg
- Product NDC
- 53329-688
- 11-digit product format
- 533290688
- Labeler code
- 53329
- Product ID
- 53329-688_2876e756-1812-62d6-e063-6394a90a4a0d
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Naproxen Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Medline Industries, LP
- Application
- ANDA090545
- Marketing category
- ANDA
- Marketing start
- 2018-08-01
- Marketing end
- 2026-06-30
- Substance
- NAPROXEN SODIUM
- Active strength
- 220 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Naproxen Sodium 220mg
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| NAPROXEN SODIUM | 220 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 9TN87S3A3C |
| Rxcui | 849574 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 53329-688-30 | Naproxen Sodium 220mg | 100 in 1 BOTTLE | TABLET | 100 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 53329-688 | NAPROXEN SODIUM 220MG (NAPROXEN SODIUM) TABLET [MEDLINE INDUSTRIES, LP] | 7 | Current NDC, Legacy NDC, 1 package rows | 20241207_6d9b3581-63b5-699e-e053-2991aa0a68f8.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 53329-688-30 | 53329068830 | 100 TABLET in 1 BOTTLE (53329-688-30) | 100 tablet | 2018-08-01 | 0000-00-00 | No | No | Current |